Adenosine uptake and deamination regulate tonic A2a receptor facilitation of evoked [3H]acetylcholine release from the rat motor nerve terminals

作者: P. Correia-de-sá , J.A. Ribeiro

DOI: 10.1016/0306-4522(96)00028-0

关键词: PharmacologyAdenosine deaminaseAdenosine receptorAdenosine A1 receptorEHNAAcetylcholineAdenosineAdenosine receptor antagonistEndocrinologyChemistryAdenosine Deaminase InhibitorInternal medicine

摘要: Abstract The actions of adenosine, adenosine deaminase, the uptake blocker, S -( p -nitrobenzyl)-6-thioinosine, and deaminase inhibitor, erythro-9(2-hydroxy-3-nonyl)adenine, on electrically evoked [ 3 H]acetylcholine release were investigated in rat phrenic nerve-hemidiaphragm preparations. Adenosine (0.25–2.5 U/ml) increased release. -Nitrobenzyl)-6-thioinosine (3–30 μM) erythro-9(2-hydroxy-3-nonyl)adenine (25 nM–50 caused biphasic effects release: at low concentrations -nitrobenzyl)-6-thioinosine (5 (50 nM) decreased release, higher than 10 MM 0.5 μM for facilitated Both -nitrobenzyl)-6-thioinosine-induced inhibition facilitation resulted from extracellular endogenous accumulation, because they blocked after inactivation with (0.5 U/ml). inhibitory both antagonized by A 1 receptor antagonist, 1,3-dipropyl-8cyclopentylxanthine (2.5 nM), whereas blockade 2a receptors PD 115,199 prevented facilitatory (30 erythro-9(2-hydroxy-3nonyl)adenine (50μM). potentiated effect y M), this when applied a concentration (3 that itself was devoid effect, excitatory Exogenously (10–500 had similar to those erythro-9(2-hydroxy-3-nonyl)adenine. reduction pretreatment 1,3-dipropyl-8-cyclopentylxanthine (2.5nM); high (100–500 μM), consistently nM)-sensitive manner. It is concluded deamination are effective removing tonically activates (A ) receptors, regulating /A receptors' activation balance.

参考文章(33)
T. W. Stone, Adenosine in the nervous system Academic Press. ,(1991)
A. J. Hutchison, M. A. Sills, R. Schulz, M. F. Jarvis, M. Williams, Un Hoi Do, [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. Journal of Pharmacology and Experimental Therapeutics. ,vol. 251, pp. 888- 893 ,(1989)
Carol E. Cass, John H. Paran, Alan R. P. Paterson, Lori R. Babb, Inhibition by nitrobenzylthioinosine of adenosine uptake by asynchronous HeLa cells. Molecular Pharmacology. ,vol. 13, pp. 1147- 1158 ,(1977)
John W. Daly, Adenosine receptors: targets for future drugs Journal of Medicinal Chemistry. ,vol. 25, pp. 197- 207 ,(1982) , 10.1021/JM00345A001
I Stojanov, K G Proctor, Pharmacological evidence for A1 and A2 adenosine receptors in the skin microcirculation. Circulation Research. ,vol. 65, pp. 176- 184 ,(1989) , 10.1161/01.RES.65.1.176
I. Wessler, H. Kilbinger, Release of [3H]acetylcholine from a modified rat phrenic nerve-hemidiaphragm preparation. Naunyn-schmiedebergs Archives of Pharmacology. ,vol. 334, pp. 357- 364 ,(1986) , 10.1007/BF00569370
Paulo Correia-de-Sá, J. Alexandre Ribeiro, Tonic adenosine A2A receptor activation modulates nicotinic autoreceptor function at the rat neuromuscular junction. European Journal of Pharmacology. ,vol. 271, pp. 349- 355 ,(1994) , 10.1016/0014-2999(94)90793-5
A.M. Sebastião, J.A. Ribeiro, On the adenosine receptor and adenosine inactivation at the rat diaphragm neuromuscular junction. British Journal of Pharmacology. ,vol. 94, pp. 109- 120 ,(1988) , 10.1111/J.1476-5381.1988.TB11505.X
J A Ribeiro, A M Sebastião, On the role, inactivation and origin of endogenous adenosine at the frog neuromuscular junction. The Journal of Physiology. ,vol. 384, pp. 571- 585 ,(1987) , 10.1113/JPHYSIOL.1987.SP016470